Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bio Buyouts
Motley Fool
Sunday, July 29, 2012 - 12:10pm
tags:
Seattle Genetics, Alexion, Regeneron, Biomarin, Vertex Pharmaceuticals, Idenix, Obagi Medical Products
Why the Shorts Are Attacking VIVUS
Motley Fool
Saturday, July 28, 2012 - 11:46am
tags:
Vivus, Qsymia
Small-Cap Adjuvants For Cancer Treatment
Seeking Alpha
Saturday, July 28, 2012 - 11:32am
tags:
Agenus, QS-21, OncoSec Medical, OMS ElectroImmunotherapy, Oncothyreon, ONO-4641, Stimuvax
Salix and Progenics Receive Complete Response Letter from FDA for Relistor sNDA
Yahoo/BusinessWire
Saturday, July 28, 2012 - 11:28am
tags:
Progenics Pharmaceuticals, Salix, Relistor, opiod-induced constipation, constipation
No Huddle Offense: Biotech Plays (video)
Yahoo/CNBC
Saturday, July 28, 2012 - 11:24am
tags:
Forget the Numbers, This Pipeline Is King
Motley Fool
Saturday, July 28, 2012 - 11:15am
tags:
Gilead Sciences, Quad, HIV, GS-7977, hepatitis C
FDA lifts import alert from Dr. Reddy's Labs Mexico facility
Yahoo/Fly on the Wall
Friday, July 27, 2012 - 1:03pm
tags:
FDA, Dr Reddy's, Mexico
Allergan Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, July 27, 2012 - 12:58pm
tags:
earnings, Allergan
With FDA panel nod, ThromboGenics closer to first potential drug
Fierce Biotech
Friday, July 27, 2012 - 12:52pm
tags:
FDA, ThromboGenics, ocriplasmin, vitreomacular adhesion
Pay Attention to These Biotechs
Yahoo/TheStreet.com
Friday, July 27, 2012 - 12:50pm
tags:
Gilead, Amgen, Celgene
Amarin Falls After U.S. Approval Limits Debut Drug’s Use
Bloomberg
Friday, July 27, 2012 - 12:17pm
tags:
Amarin, FDA, Vascepa
Vertex Pharma receives European OK for Kalydeco
Yahoo/AP
Friday, July 27, 2012 - 12:07pm
tags:
Europe, Kalydeco, Vertex Pharma, cystic fibrosis
6 Biotech Stocks That Analysts Give The Green Light
Seeking Alpha
Friday, July 27, 2012 - 12:05pm
tags:
GTx, Illumina, InterMune, QLT, Seattle Genetics, Vivus
Gilead Begins Single Pill Hepatitis C Study For 2014 Approval
Bloomberg
Friday, July 27, 2012 - 12:02pm
tags:
GS-7977, hepatitis C, Gilead
3 Healthcare Mid Caps With Strong EPS Growth Projections And Analyst Backing
Seeking Alpha
Friday, July 27, 2012 - 11:55am
tags:
Vivus, Biomarin, Alkermes
Amgen, Gilead Pop After Quarterly Earnings Beats
Investors.com
Friday, July 27, 2012 - 11:41am
tags:
earnings, Amgen, Gilead
Sequenom shares fall after 2Q misses expectations
Yahoo/AP
Friday, July 27, 2012 - 11:39am
tags:
Sequenom, earnings
Bristol-Myers Gets Record Low Coupons In $2 Billion Debt Issue
Bloomberg
Friday, July 27, 2012 - 11:38am
tags:
Bristol-Myers Squibb, debt
India considers price controls for patented drugs
Reuters
Friday, July 27, 2012 - 11:36am
tags:
India
Alzheimer’s Setback Makes Elan Takeover Bait To Biogen
Bloomberg
Friday, July 27, 2012 - 8:17am
tags:
Elan, Biogen Idec, Alzheimer's disease, M&A, bapineuzumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.